Cargando…
Clinical outcome is significantly better with spheroid-based autologous chondrocyte implantation manufactured with more stringent cell culture criteria
OBJECTIVE: Spherox (CO.DON AG) is an autologous chondrocyte implantation (ACI) product, consisting of spheroids of human autologous matrix-associated chondrocytes. The tendency of primary chondrocytes to dedifferentiate during cultivation and the high biologic variability caused by the autologous na...
Autores principales: | Eschen, C., Kaps, C., Widuchowski, W., Fickert, S., Zinser, W., Niemeyer, Ph, Roël, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718150/ https://www.ncbi.nlm.nih.gov/pubmed/36474562 http://dx.doi.org/10.1016/j.ocarto.2020.100033 |
Ejemplares similares
-
A Prospective, Randomized, Open-Label, Multicenter, Phase III Noninferiority Trial to Compare the Clinical Efficacy of Matrix-Associated Autologous Chondrocyte Implantation With Spheroid Technology Versus Arthroscopic Microfracture for Cartilage Defects of the Knee
por: Niemeyer, Philipp, et al.
Publicado: (2019) -
Role of Matrix-Associated Autologous Chondrocyte Implantation with Spheroids in the Treatment of Large Chondral Defects in the Knee: A Systematic Review
por: Vonk, Lucienne Angela, et al.
Publicado: (2021) -
Safety and Efficacy of Matrix-Associated Autologous Chondrocyte
Implantation With Spheroids for Patellofemoral or Tibiofemoral Defects: A 5-Year
Follow-up of a Phase 2, Dose-Confirmation Trial
por: Hoburg, Arnd, et al.
Publicado: (2022) -
Safety of three different product doses in autologous chondrocyte implantation: results of a prospective, randomised, controlled trial
por: Becher, Christoph, et al.
Publicado: (2017) -
Matrix-Associated Autologous Chondrocyte Implantation Is an Effective Treatment at Midterm Follow-up in Adolescents and Young Adults
por: Hoburg, Arnd, et al.
Publicado: (2019)